Montelukast for persistent asthma.
Szczeklik
A
A
Mastalerz
L
L
Nizankowska
E
E
Sanak
M
M
D000085:Acetates / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects; D001249:Asthma / Q000139:chemically induced / Q000188:drug therapy*; D003521:Cyclopropanes; D006801:Humans; D017999:Leukotriene E4 / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D011804:Quinolines; D013440:Sulfides; D017999:Leukotriene E4; C093875:montelukast; D001241:Aspirin; D011241:Prednisone